Sector portfolio · Corporate investor · Switzerland
Roche Venture Fund's Biotech portfolio
Roche Venture Fund has backed 11 Biotech startups in rounds we track, $1.2B between them, shown by the stage each has reached. The best-funded is Freenome.
Funding by segment
- Series B$116M3
- Series C and later$283M3
- Series A$159M3
- Stage not reported$665M2
Where they are based
- United States9$1.1B
- Spain1$57M
- United Kingdom1$113M
United States
Spain
United KingdomFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M3
- $50M to $250M7
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- Spain1
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Series B
3 startups · $116M raised
COUR PharmaCOUR Pharma is a clinical-stage biotechnology company based in Skokie, Illinois, focused on developing innovative therapies for auUnited States$50M
Stratos GenomicsStratos Genomics is a biotechnology company based in Seattle, founded in 2007.United States$36M
OmiciaGlobal healthcare platform for genomics-driven precision medicine.United States$30M
Series C and later
3 startups · $283M raised
- SSutroVaxUnited States$167M
Purigen BiosystemsPurigen Biosystems is a biotechnology company based in Pleasanton, California, founded in 2012.United States$62M
MacuLogixMacuLogix focuses on detecting and tracking age-related macular degeneration.United States$54M
Series A
3 startups · $159M raised
- TTiomaUnited States$86M
Minoryx TherapeuticsMinoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.Spain$57M- BBiodesyBiodesy develops a novel system to analyze real-time protein function for research and clinical applications.United States$15M
Stage not reported
2 startups · $665M raised
FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developmeUnited Kingdom$113M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Roche Venture Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Roche Venture Fund?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.